TALAVERA ANDUJAR, B. (2024). METABOLOMICS AND EXPOSOMICS APPROACHES TO BETTER UNDERSTAND NEURODEGENERATIVE DISEASES USING CHEMINFORMATICS TOOLS AND HIGH-RESOLUTION MASS SPECTROMETRY [Doctoral thesis, Unilu - University of Luxembourg]. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/61575 |
BUOSO, C., Seifert, M., Lang, M., GRIFFITH, C., TALAVERA ANDUJAR, B., Rueda, M. P. C., Fischer, C., Doerrier, C., Talasz, H., Zanon, A., Pramstaller, P. P., SCHYMANSKI, E., Pichler, I., & Weiss, G. (2024). Dopamine‑iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease. Neurobiology of Disease, 106506. doi:10.1016/j.nbd.2024.106506 Peer Reviewed verified by ORBi |
TALAVERA ANDUJAR, B., MARY, A., VENEGAS MALDONADO, C. J., Cheng, T., Zaslavsky, L., Bolton, E., HENEKA, M., & SCHYMANSKI, E. (2023). Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer’s Disease Patients? (2). ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/58891. doi:10.26434/chemrxiv-2023-6j2gm-v2 |
TALAVERA ANDUJAR, B., MARY, A., VENEGAS MALDONADO, C. J., Cheng, T., Zaslavsky, L., Bolton, E. E., HENEKA, M., & SCHYMANSKI, E. (21 September 2023). YoungNMC 2023: "Challenges in Developing Non-target Exposomics and Metabolomics Workflows for Cerebrospinal Fluid from Alzheimer's disease and Mild Cognitive Impairment" [Paper presentation]. YoungNMC Symposium, Nijmegen, Netherlands. doi:10.5281/ZENODO.8364324 Peer reviewed |
TALAVERA ANDUJAR, B., MARY, A., Cheng, T., Zaslavsky, L., Bolton, E., HENEKA, M., & SCHYMANSKI, E. (2023). Non-target LC-HRMS to Study the Exposome of Mild Cognitive Impairment and Alzheimer’s Disease on Cerebrospinal Fluid. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/57734. doi:10.26434/chemrxiv-2023-6j2gm |
TALAVERA ANDUJAR, B., MARY, A., Cheng, T., Zaslavsky, L., Bolton, E. E., HENEKA, M., & SCHYMANSKI, E. (07 June 2023). Non-target LC-HRMS to Study the Exposome of Mild Cognitive Impairment and Alzheimer's Disease on Cerebrospinal Fluid [Poster presentation]. 19th Annual International Conference of the Metabolomics Society, Niagara Falls, Canada. doi:10.5281/ZENODO.8017622 Peer reviewed |
TALAVERA ANDUJAR, B., AURICH, D., AHO, V., Singh, R. R., Cheng, T., Zaslavsky, L., Bolton, E. E., Mollenhauer, B., WILMES, P., & SCHYMANSKI, E. (2022). Studying the Parkinson's disease metabolome and exposome in biological samples through different analytical and cheminformatics approaches: a pilot study. Analytical and Bioanalytical Chemistry. doi:10.1007/s00216-022-04207-z Peer Reviewed verified by ORBi |
Iturrospe, E., Da Silva, K. M., TALAVERA ANDUJAR, B., Cuykx, M., Boeckmans, J., Vanhaecke, T., Covaci, A., & Van Nuijs, A. L. N. (2020). An exploratory approach for an oriented development of an untargeted hydrophilic interaction liquid chromatography-mass spectrometry platform for polar metabolites in biological matrices. Journal of Chromatography. A. doi:10.1016/j.chroma.2020.461807 Peer Reviewed verified by ORBi |